NCT02180672View on ClinicalTrials.gov

Steroids for Pediatric Apnea Research in Kids

PHASE3CompletedINTERVENTIONAL
Enrollment

211

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

December 30, 2019

Study Completion Date

October 30, 2021

Conditions
Obstructive Sleep Apnea Syndrome
Interventions
DRUG

Nasal Fluticasone

One spray per nostril, per day.

DRUG

Placebo

One spray per nostril, per day.

Trial Locations (1)

19104

Children's Hospital of Philadelphia, Philadelphia

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Children's Hospital of Philadelphia

OTHER

NCT02180672 - Steroids for Pediatric Apnea Research in Kids | Biotech Hunter | Biotech Hunter